Robot assisted radical prostatectomy for elderly patients with high risk prostate cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 2, 2013, Pages 193-197

  Rogers, Craig G ^a   Sammon, Jesse D ^a   Sukumar, Shyam ^a   Diaz, Mireya ^a   Peabody, James ^a   Menon, Mani ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Elderly; High risk; Prostate cancer; Radical prostatectomy; Robotic prostatectomy; Robotics

Indexed keywords

HORMONE; PROSTATE SPECIFIC ANTIGEN;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER STAGING; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; ILEUS; INTERNATIONAL PROSTATE SYMPTOM SCORE; LENGTH OF STAY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; QUESTIONNAIRE; ROBOT ASSISTED RADICAL PROSTATECTOMY; ROBOTICS; TREATMENT OUTCOME; URINE INCONTINENCE;

AGED; DISEASE-FREE SURVIVAL; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; ROBOTICS;

EID: 84875274036     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.11.018     Document Type: Article

References (31)

1. Fitzpatrick J.M. Management of localized prostate cancer in senior adults: The crucial role of comorbidity. BJU Int 2008, 101(Suppl):16-22.
2. Stangelberger A., Waldert M., Djavan B. Prostate cancer in elderly men. Rev Urol 2008, 10:111-119.
3. Albertsen P.C., Hanley J.A., Gleason D.F., et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998, 280:975-980.
4. Magheli A., Rais-Bahrami S., Humphreys E.B., et al. Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol 2007, 178:1933-1937. Discussion 7-8.
5. Malaeb B.S., Rashid H.H., Lotan Y., et al. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts. Urol Oncol 2007, 25:291-297.
6. Siddiqui S.A., Sengupta S., Slezak J.M., et al. Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. J Urol 2006, 175:952-957.
7. Zelefsky M.J., Eastham J.A., Cronin A.M., et al. Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: A comparison of clinical cohorts adjusted for case mix. J Clin Oncol 2010, 28:1508-1513.
8. Greco K.A., Meeks J.J., Wu S., et al. Robot-assisted radical prostatectomy in men aged ≥ 70 years. BJU Int 2009, 104:1492-1495.
9. Shikanov S., Desai V., Razmaria A., et al. Robotic radical prostatectomy for elderly patients: Probability of achieving continence and potency 1 year after surgery. J Urol 2010, 183:1803-1807.
10. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998, 280:969-974.
11. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987, 40:373-383.
12. Menon M., Shrivastava A., Bhandari M., et al. Vattikuti Institute prostatectomy: Technical modifications in 2009. Eur Urol 2009, 56:89-96.
13. Fowler F.J., McNaughton Collins M., Albertsen P.C., et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000, 283:3217-3222.
14. Minino A.M., Smith B.L. Deaths: Preliminary data for 2000. Natl Vital Stat Rep 2001, 49:1-40.
15. Jani A.B., Johnstone P.A., Liauw S.L., et al. Age and grade trends in prostate cancer (1974-2003): A Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol 2008, 31:375-378.
16. Albertsen P.C., Hanley J.A., Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005, 293:2095-2101.
17. Rogers C.G., Su L.M., Link R.E., et al. Age stratified functional outcomes after laparoscopic radical prostatectomy. J Urol 2006, 176:2448-2452.
18. Yossepowitch O., Eggener S.E., Bianco F.J., et al. Radical prostatectomy for clinically localized, high risk prostate cancer: Critical analysis of risk assessment methods. J Urol 2007, 178:493-499. Discussion 9.
19. Carver B.S., Bianco F.J., Scardino P.T., et al. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. J Urol 2006, 176:564-568.
20. Loeb S., Smith N.D., Roehl K.A., et al. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer. Urology 2007, 69:1170-1175.
21. Ward J.F., Slezak J.M., Blute M.L., et al. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005, 95:751-756.
22. Berglund R.K., Jones J.S., Ulchaker J.C., et al. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: A prospective analysis. Urology 2006, 67:1253-1256.
23. Hachiya T., Akakura K., Saito S., et al. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan. BJU Int 2005, 95:534-540.
24. Powell I.J., Tangen C.M., Miller G.J., et al. Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year follow-up, Phase II Southwest Oncology Group Study 9109. J Urol 2002, 168:2016-2019.
25. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997, 277:1445-1451.
26. Cooperberg M.R., Grossfeld G.D., Lubeck D.P., et al. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst 2003, 95:981-989.
27. Lau W.K., Bergstralh E.J., Blute M.L., et al. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: Influence of concomitant pathological variables. J Urol 2002, 167:117-122.
28. Alibhai S.M., Krahn M.D., Cohen M.M., et al. Is there age bias in the treatment of localized prostate carcinoma?. Cancer 2004, 100:72-81.
29. Schwartz K.L., Alibhai S.M., Tomlinson G., et al. Continued undertreatment of older men with localized prostate cancer. Urology 2003, 62:860-865.
30. Ketchandji M., Kuo Y.F., Shahinian V.B., et al. Cause of death in older men after the diagnosis of prostate cancer. J Am Geriatr Soc 2009, 57:24-30.
31. Abdollah F., Sun M., Thuret R., et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients 1988-2006. Eur Urol 2011, 59:88-95.